Scientific Program
Download the full program.
Thursday, February 11th, 2010 |
|
| 17:00 – 17:30 | Opening Ceremony Philip Low President 1st International Congress on Alzheimer’s & Advanced Neurotechnologies |
| 17:30 – 19:30 | What Do We Know About Alzheimer’s Disease? |
|---|---|
| 17:30 | 100 Years of Alzheimer Research Paul Aisen Director, Alzheimer’s Disease Cooperative Study (ADCS) Professor, UCSD Medical School |
| 18:00 | Special NeuroVigil Lecture : Mechanisms underlying neuronal injury and degeneration Peter St. George-Hyslop Director, Center for Research in Neurodegenerative Disease, University of Toronto Howard Hughes Medical Institute |
| 19:00 | The Amyloid Hypothesis Frederic Checler Research Director INSERM Institut de Pharmacologie Moléculaire et Cellulaire Valbonne |
| 19:30 | Welcome Cocktail Courtesy Direction du Tourisme et des Congrès de la Principauté de Monaco |
Friday, February 12th, 2010 |
|
| 9:00 – 11:00 | Advances in Biomarkers and Modeling for the Development of Improved Therapeutics |
| 9:00 | Biomarkers and Alzheimer’s Gabriel Vargas Head of the CNS Clinical Biomarker Group Roche |
| 9:30 | Early Alzheimer’s Treatment Eric Siemers Medical Director, Alzheimer’s Disease Team Eli Lilly |
| 10:00 | Integrating Biomarkers and Informatics Strategies into Immunotherapeutic Approaches to Treating Alzheimer’s Disease Husseini Manji Vice President, CNS & Pain, Pharmaceutical Research and Development Johnson & Johnson |
| 10:30 | Clinical Trails from MCI to Dementia – Refining Study Designs Jesse Cedarbaum Vice President, Clinical Development Elan Pharmaceuticals |
| 11:00 – 11:30 | Coffee Break |
| 11:30 – 13:00 | Creating New Institutions to Enable New Technologies |
| 11:30 | Drugs for AD. Is the single target-based approach going to work? Dave Schubert Head, Cellular Neurobiology Lab The Salk Intistute for Biological Studies |
| 12:00 | NeuroVigil: Sleep as a Gateway into the Brain Philip Low Founder, Chairman, CEO, NeuroVigil Adjunct Professor, Stanford School of Medicine Visiting Professor, MIT Media Lab Research Affiliate, Salk Institute |
| 12:30 | A New Alzheimer’s Foundation Linda Avey Co-Founder, 23andMe |
| 13:00 – 14:00 | Lunch & Poster Session |
| 14:00 – 15:30 | Home-based & Wireless Health |
| 14:00 | New Technologies to Assess Cognition at Home Jeffrey Kaye Director, Layton Aging & Alzheimer’s Disease Center Oregon Health & Science University |
| 14:30 | The Wireless Health Revolution Don Jones Vice President, Health and Life Sciences QUALCOMM |
| 15:00 | iBrain: Home Monitoring of EEGs Mike Chi NeuroVigil UCSD Electrical Engineering |
| 15:30 – 15:40 | Coffee Break |
| 15:40 | A New Runway in the Treatment of Alzheimer’s Disease? Etienne-Emile Baulieu Director, INSERM Lasker Award Winner |
| 16:10 | New Criteria for Alzheimer’s Disease & Ongoing Validation Bruno Dubois Director, Center for Cognitive and Behavioral Diseases Director, INSERM U610, Hôpital La Salpêtrière |
| 16:40 | The French Alzheimer’s Plan Florence Lustman Head of France’s Alzheimer’s Programme |
| 17:10 – 18:10 | Panel Discussion on Patient Rights and Patient Awareness
Co-Moderator: Jean-Paul Spire, University of Chicago Participants: Paul Aisen Sonia Ancoli-Israel Bruno Dubois Jean-Paul Spire (Co-Moderator) Alain Pesce Jacques Touchon Bruno Vellas |
| 20:30 | Meeting of the Minds Gala Hotel Fairmont Monte Carlo Wine courtesy B.Févral, Terroirs Diffusion Tango Show courtesy UBS |
Saturday, February 13th, 2010 |
|
| 8:30 – 10:30 | Sleep Disorders, a Major Cause of Hospitalization |
| 8:30 | Altered Sleep Patterns and Insomnia in Alzheimer’s Sonia Ancoli-Israel Director, Gillin Sleep and Chronobiology Research Center Professor, UCSD Medical School |
| 9:00 | Genetic Moderators of Sleep Apnea and Risk for AD Ruth O’Hara Professor, Psychiatry and Behavioral Sciences Stanford School of Medicine |
| 9:30 | Enabling Systematic Neuroscience with Novel Optical Neural Control Strategies Ed Boyden Co-Director, MIT Media Lab Center for Human Augmentation MIT Media Lab, McGovern Inst. for Brain Research, MIT Picower Institute for Learning and Memory |
| 10:00 | Optical Neural Control of Sleep in Alzheimer’s Luis de Lecea Professor, Psychiatry and Behavioral Sciences Stanford School of Medicine |
| 10:30 – 11:00 | Coffee Break |
| 11:00 – 13:00 | Early Disease Onset and Prevention |
| 11:00 | Molecular Imaging in Early Detection of Alzheimer’s Disease Jorge Barrio Chair in Gerontology David Geffen UCLA School of Medicine |
| 11:30 | Prevention and Clinical Trials Sandrine Andrieu Professor, Department of Epidemiology University of Toulouse |
| 12:00 | New Technologies to Assess Cognition at Home Jeffrey Kaye Director, Layton Aging & Alzheimer’s Disease Center Oregon Health & Science University |
| 12:30 – 13:30 | Lunch |
| 13:30 | Unraveling the mysteries of Dementia with lewy bodies and associated disorders: The Monaco, Nice, Montreal (MNM) Initiative. Oury Monchi Centre de recherche de l’ Institut universitaire de Gériatrie de Montréal, Université de Montréal, Montréal, Canada |
| 14:00 | Diabetes: a Strong Risk Factor for Alzheimer’s Pamela Maher Michael J. Fox Foundation Award Recipient Cellular Neurbiology Lab, Salk Institute |
| 14:30 | Endgame: The Late Disease Onset Ugo Lucca Head of Laboratory of Geriatric Neuropsychiatry Institute of Pharmacological Research Mario Negri |
| 15:00 – 15:10 | Coffee Break |
| 15:10 – 17:10 | Workshop: Governmental and Private Initiatives |
| 15:10 | Panel Discussion: Future of Alzheimer’s All Speakers. |
| 15:50 | The European, American and International Collaborations
Participants: Paul Aisen Bruno Vellas Michael Weiner |
| 16:30 | Last but not Least: The Highly Important Role of Foundations and Philanthropy in Medical Research Co-Moderator : Joel Soler, Cinéma Vérité Participants: Linda Avey Bernadette Chirac Manuela Consensi-Dini Olivier de Ladoucette Frederic & Samareh Lajaunias Federico Palermiti Catherine Pastor Martin Prince Joel Soler (Co-Moderator) Jean Spiri |
| 17:10 | Closing Remarks: What have we learned and what should we not forget? Philip Low President 1st International Congress on Alzheimer’s & Advanced Neurotechnologies |